Cumberland Pharmaceuticals Inc. Current Assets
Cumberland Pharmaceuticals Inc. (CPIX) had Current Assets of $33.64 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $33.64M.
- 2026-03-31: Assets, Current $32.79M.
- 2025-12-31: Assets, Current $37.06M.
- 2025-09-30: Assets, Current $29.94M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $33.64M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $32.79M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $37.06M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $29.94M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $31.21M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $31.88M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $36.45M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $35.24M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $35.58M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $36.21M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $35.71M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $41.77M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $43.67M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $43.81M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $45.87M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $49.16M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $43.75M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $45.34M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $45.69M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $47.22M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $46.68M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $49.38M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $49.97M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $48.89M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $45.75M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $44.74M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $50.16M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $49.40M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $51.93M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $57.97M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $59.12M 8-K · filed 2020-12-10 | |
| 2018-09-30 | $63.63M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $66.65M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $66.82M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $68.68M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $66.08M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $63.29M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $63.54M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $65.55M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $66.96M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $63.99M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $64.92M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $64.58M 10-K · filed 2017-03-13 | $67.11M 10-K · filed 2016-03-14 |
| 2015-09-30 | $67.72M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $68.20M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $67.55M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $70.81M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $70.15M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $70.63M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $69.27M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $68.68M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $78.27M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $82.44M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $86.02M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $87.23M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $86.79M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $86.26M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $86.28M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $87.31M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $85.88M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $84.34M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $81.04M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |